RN7SL230P

Across TCGA pan-cancer cohorts, RN7SL230P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL230P’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RN7SL230P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL230P is over-expressed in tumor, although a few such as UCEC and READ show the opposite, repressed pattern.

UCEC, READ, and KIRP are the cancer types where RN7SL230P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL230P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	II,III,IV	−0.313	.028	4	view →
READ	All	All	−0.157	.023	2	view →
KIRP	Male	All	−0.117	.002	2	view →
HNSC	Male	II,III,IV	+0.088	.024	2	view →
LUAD	All	All	+0.374	.018	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL230P–UCEC

Open the UCEC breakdown →